Three Documents Shared With COVAXIN

As COVAXIN is under restricted use for emergency situations and under the clinical trial mode, every participant who receives this vaccine is being given three documents along with the vaccine shot. A fact sheet in all regional languages that describes the vaccine and who is eligible to receive it, an informed consent sheet that the recipients are expected to sign, and a form for filling in details of any adverse events following immunisation. 

The form for AEFI has to be filled by the beneficiaries after a designated doctor calls them daily for seven days as follow up to check for any side effects after immunisation.